These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 33517123)
1. Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-070-02) from a patient with neurodegeneration with brain iron accumulation (NBIA) having compound heterozygous mutations in PANK2 gene. Ou-Yang CH; Tai CH; Lin HY; Huang CY; Lin CH Stem Cell Res; 2021 Mar; 51():102190. PubMed ID: 33517123 [TBL] [Abstract][Full Text] [Related]
2. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene. Lin HY; Ou-Yang CH; Lin CH Stem Cell Res; 2020 Dec; 49():102032. PubMed ID: 33068888 [TBL] [Abstract][Full Text] [Related]
3. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes. Kurian MA; Hayflick SJ Int Rev Neurobiol; 2013; 110():49-71. PubMed ID: 24209433 [TBL] [Abstract][Full Text] [Related]
4. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation. Álvarez-Córdoba M; Fernández Khoury A; Villanueva-Paz M; Gómez-Navarro C; Villalón-García I; Suárez-Rivero JM; Povea-Cabello S; de la Mata M; Cotán D; Talaverón-Rey M; Pérez-Pulido AJ; Salas JJ; Pérez-Villegas EM; Díaz-Quintana A; Armengol JA; Sánchez-Alcázar JA Mol Neurobiol; 2019 May; 56(5):3638-3656. PubMed ID: 30173408 [TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration with brain iron accumulation. Hayflick SJ; Kurian MA; Hogarth P Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618 [TBL] [Abstract][Full Text] [Related]
7. PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease. Matarin MM; Singleton AB; Houlden H Neurosci Lett; 2006 Oct; 407(2):162-5. PubMed ID: 16962235 [TBL] [Abstract][Full Text] [Related]
8. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Thomas M; Hayflick SJ; Jankovic J Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358 [TBL] [Abstract][Full Text] [Related]
9. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration. Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086 [TBL] [Abstract][Full Text] [Related]
10. Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives. Álvarez-Córdoba M; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Salas JJ; Sánchez-Alcázar JA Orphanet J Rare Dis; 2021 May; 16(1):201. PubMed ID: 33952316 [TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels. Talaverón-Rey M; Álvarez-Córdoba M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Gómez-Fernández D; Romero-González A; Suárez-Carrillo A; Munuera-Cabeza M; Cilleros-Holgado P; Reche-López D; Piñero-Pérez R; Sánchez-Alcázar JA Orphanet J Rare Dis; 2023 Apr; 18(1):80. PubMed ID: 37046296 [TBL] [Abstract][Full Text] [Related]
12. Clinical and Imaging Presentation of a Patient with Beta-Propeller Protein-Associated Neurodegeneration, a Rare and Sporadic form of Neurodegeneration with Brain Iron Accumulation (NBIA). Hattingen E; Handke N; Cremer K; Hoffjan S; Kukuk GM Clin Neuroradiol; 2017 Dec; 27(4):481-483. PubMed ID: 28643035 [TBL] [Abstract][Full Text] [Related]
14. Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. Kotzbauer PT; Truax AC; Trojanowski JQ; Lee VM J Neurosci; 2005 Jan; 25(3):689-98. PubMed ID: 15659606 [TBL] [Abstract][Full Text] [Related]
15. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270 [TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation. Wang ZB; Liu JY; Xu XJ; Mao XY; Zhang W; Zhou HH; Liu ZQ Biomed Pharmacother; 2019 Oct; 118():109068. PubMed ID: 31404774 [TBL] [Abstract][Full Text] [Related]
17. Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration. Cheng Y; Liu YT; Yang ZH; Yang J; Shi CH; Xu YM Int J Neurosci; 2018 Dec; 128(12):1109-1113. PubMed ID: 29962256 [TBL] [Abstract][Full Text] [Related]
18. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Hayflick SJ Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201 [TBL] [Abstract][Full Text] [Related]